|
|
|
Insider
Information: |
Craig Adam R |
Relationship: |
President and CEO, Dir... |
City: |
New York |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
23,452 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$5,277 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
23,452 |
|
|
Total
Value |
$5,277 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
1
|
0
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
Percentage
Gain/Loss : |
-10.9%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Viracta Therapeutics Ord Shs |
VIRX |
EVP, Development & CMO |
2015-02-27 |
23,452 |
2013-02-28 |
0 |
Premium* |
|
Cti Biopharma Corporation |
CTIC |
President and CEO, Dir... |
2023-06-26 |
0 |
2020-07-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
36 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
VIRX |
Viracta Therapeutics Ord ... |
EVP, Development & CMO |
|
2013-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
7,662 |
10,257 |
0 |
- |
|
VIRX |
Viracta Therapeutics Ord ... |
EVP, Development & CMO |
|
2014-08-27 |
4 |
AS |
$8.00 |
$20,432 |
D/D |
(2,554) |
12,723 |
0 |
- |
|
VIRX |
Viracta Therapeutics Ord ... |
EVP, Development & CMO |
|
2015-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
19,031 |
31,754 |
0 |
- |
|
VIRX |
Viracta Therapeutics Ord ... |
EVP, Development & CMO |
|
2015-02-27 |
4 |
D |
$2.22 |
$18,430 |
D/D |
(8,302) |
23,452 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
President and CEO |
|
2020-07-01 |
4 |
A |
$0.98 |
$4,900 |
D/D |
5,000 |
5,000 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
President and CEO |
|
2021-12-31 |
4 |
A |
$2.11 |
$6,699 |
D/D |
3,178 |
16,678 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
President and CEO |
|
2022-06-01 |
4 |
AS |
$6.00 |
$162,000 |
D/D |
(27,000) |
16,678 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
President and CEO |
|
2022-06-01 |
4 |
OE |
$0.84 |
$22,710 |
D/D |
27,000 |
43,678 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
President and CEO |
|
2022-06-02 |
4 |
OE |
$0.84 |
$22,710 |
D/D |
27,000 |
43,678 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
President and CEO |
|
2022-06-02 |
4 |
AS |
$6.00 |
$162,000 |
D/D |
(27,000) |
16,678 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
President and CEO |
|
2022-06-03 |
4 |
OE |
$0.84 |
$15,327 |
D/D |
18,223 |
34,901 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
President and CEO |
|
2022-06-03 |
4 |
AS |
$6.01 |
$109,520 |
D/D |
(18,223) |
16,678 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
President and CEO |
|
2022-06-30 |
4 |
A |
$2.12 |
$13,086 |
D/D |
6,183 |
22,861 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
President and CEO |
|
2022-07-01 |
4 |
OE |
$0.84 |
$22,710 |
D/D |
27,000 |
49,861 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
President and CEO |
|
2022-07-01 |
4 |
AS |
$6.00 |
$162,000 |
D/D |
(27,000) |
22,861 |
0 |
% |
|
CTIC |
Cti Biopharma Corporation |
President and CEO |
|
2022-07-05 |
4 |
OE |
$0.84 |
$22,710 |
D/D |
27,000 |
49,861 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
President and CEO |
|
2022-07-05 |
4 |
AS |
$6.00 |
$162,000 |
D/D |
(27,000) |
22,861 |
0 |
% |
|
CTIC |
Cti Biopharma Corporation |
President and CEO |
|
2022-07-06 |
4 |
AS |
$6.11 |
$111,343 |
D/D |
(18,223) |
22,861 |
0 |
% |
|
CTIC |
Cti Biopharma Corporation |
President and CEO |
|
2022-07-06 |
4 |
OE |
$0.84 |
$15,327 |
D/D |
18,223 |
41,084 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
President and CEO |
|
2022-08-16 |
4 |
B |
$5.50 |
$27,500 |
D/D |
5,000 |
27,861 |
2.81 |
% |
|
CTIC |
Cti Biopharma Corporation |
President and CEO |
|
2022-09-12 |
4 |
OE |
$0.84 |
$203,799 |
D/D |
242,300 |
270,161 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
President and CEO |
|
2022-09-12 |
4 |
AS |
$6.43 |
$1,557,989 |
D/D |
(242,300) |
27,861 |
0 |
% |
|
CTIC |
Cti Biopharma Corporation |
President and CEO |
|
2022-11-09 |
4 |
OE |
$0.84 |
$45,416 |
D/D |
53,996 |
81,857 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
President and CEO |
|
2022-11-09 |
4 |
AS |
$6.00 |
$324,056 |
D/D |
(53,996) |
27,861 |
0 |
% |
|
CTIC |
Cti Biopharma Corporation |
President and CEO |
|
2022-11-10 |
4 |
AS |
$6.00 |
$1,130,703 |
D/D |
(188,304) |
27,861 |
0 |
% |
|
36 Records found
|
|
Page 1 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|